Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 1/20 | 0.40 |
| ▸ | GNB1 | P62873 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 9/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.35 |
| ▸ | WNT3A | P56704 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30563103 | 1.00 | GNG2 (0.40) | GNG2GNB1GSK3BPTPN1ATM | |
| SCHEMBL21886542 | 0.89 | CTNNB1 (0.42) | CTNNB1WNT3AHPGD | |
| SCHEMBL14357334 | 0.87 | ATM (0.50) | ATMMEN1KMT2ARXRACTNNB1 | |
| SCHEMBL27636279 | 0.86 | ATM (0.36) | ATMMEN1KMT2ARXRACTNNB1 | |
| SCHEMBL960318 | 0.84 | MAPT (0.46) | KMT2ARXRAHPGDALDH1A1MAPT | |
| SCHEMBL14898029 | 0.82 | RXRA (0.50) | MEN1KMT2ARXRAALDH1A1MAPT | |
| SCHEMBL925100 | 0.82 | KMT2A (0.36) | ATMMEN1KMT2ARXRACTNNB1 | |
| SCHEMBL27617374 | 0.81 | KMT2A (0.38) | MEN1KMT2ARXRAHPGDALDH1A1 | |
| SCHEMBL14898177 | 0.80 | CA12 (0.45) | ATMMEN1KMT2AHPGDALDH1A1 | |
| SCHEMBL13510942 | 0.80 | RXRA (0.32) | ATMMEN1KMT2ARXRACTNNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114409552-B | Levorotatory sand hydrochloride preparation method of butylamine alcohol | 广州博济生物医药科技园有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-114736186-B | Method for synthesizing Violet Luo Zhongjian body from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-114736186-A | Method for synthesizing vilanterol intermediate from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2022-07-12 | — | — | CN | claimed |
| EP-3201171-B1 | METHOD OF PREPARING INTERMEDIATE OF SALMETEROL | AMPHASTAR NANJING PHARMACEUTICALS INC (CN) | 2020-04-15 | — | — | EP | claimed |
| WO-2017001907-A1 | BIOCATALYTIC PROCESSES FOR THE PREPARATION OF VILANTEROL | TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) | 2017-01-05 | — | — | WO | claimed |
| CN-114409552-B | Levorotatory sand hydrochloride preparation method of butylamine alcohol | 广州博济生物医药科技园有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-114736186-B | Method for synthesizing Violet Luo Zhongjian body from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-114736186-B | Method for synthesizing Violet Luo Zhongjian body from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2023-08-08 | — | — | CN | disclosed |
| WO-2023097696-A1 | METHOD FOR SYNTHESIZING (1R)-1-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)-2-NITROETHANOL | 广东莱佛士制药技术有限公司 | 2023-06-08 | — | — | WO | disclosed |
| WO-2023097678-A1 | METHOD FOR SYNTHESIZING (R)-5-(2,2-DIMETHYL-4H-BENZO[D][1,3]DIOXIN-6-YL)OXAZOLIDIN-2-ONE | 广东莱佛士制药技术有限公司 | 2023-06-08 | — | — | WO | disclosed |
| CN-114736186-A | Method for synthesizing vilanterol intermediate from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-114736186-A | Method for synthesizing vilanterol intermediate from tert-butyl carbamate | 安徽德信佳生物医药有限公司 | 2022-07-12 | — | — | CN | disclosed |
| EP-0894787-A1 | 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXYLATE DERIVATIVES | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1999-02-03 | — | — | EP | disclosed |
| EP-0882704-A1 | 3,4-DISUBSTITUTED PHENYLETHANOLAMINOTETRALINCARBOXAMIDE DERIVATIVES | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5243076-A | Adrenergic stimulant intermediates | GLAXO GROUP LTD. | 1993-09-07 | — | — | US | disclosed |
| US-5225445-A | Respiratory system disorders | GLAXO GROUP LTD. | 1993-07-06 | — | — | US | disclosed |
| US-5126375-A | Asthma, chronic bronchitis | GLAXO GROUP LTD. (GB) | 1992-06-30 | — | — | US | disclosed |
| US-5091422-A | Treating inflammatory or allergic skin disease, lowering gastric acidity | GLAXO GROUP LIMITED (GB) | 1992-02-25 | — | — | US | disclosed |
| US-4992474-A | Adrenergic stimulants | GLAXO GROUP LTD. (GB) | 1991-02-12 | — | — | US | disclosed |
| US-4990505-A | Treating asthma, bronchitis; adrenergic stimulants | GLAXO GROUP LIMITED (GB) | 1991-02-05 | — | — | US | disclosed |